First‑ever reverse‑aging drug has entered human trials

The first reverse‑aging drug has entered human trials. Scientists administered the experimental treatment via injection. The procedure marks a milestone in anti‑aging research. Researchers are monitoring the patient for safety and efficacy. The study will assess whether the drug can reverse cellular aging. Early results are expected to guide future clinical development. The trial follows pre‑clinical studies that showed promising results. The medical community will watch for breakthroughs in age‑related diseases.